Sustained clinical responses seen with neuroimmune modulation for rheumatoid arthritis
Twenty-four-month data show sustained clinical responses for patients receiving neuroimmune modulation therapy for rheumatoid arthritis (RA), according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Source: medicalxpress.com